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ABSTRACT  
   
Cardiovascular disease has reached epidemic proportions resulting in its ranking 
as the number one cause of mortality in the Western world. A key player in the 
pathophysiology of vascular disease is oxidative stress due to free radical accumulation. 
This intervention study was conducted to evaluate any potential mediation of oxidative 
stress using a soil-derived organometallic compound (OMC) with suspected antioxidant 
properties. A 10-week study was conducted in male Sprague-Dawley rats (n = 42) fed 
either a high-fat diet (HFD) consisting of 60% kcal from fat or a standard Chow diet 
containing only 6% kcals from fat. Rats from each diet group were then subdivided into 3 
subgroups (n = 6-10 each) that received 0.0 mg/mL, 0.6 mg/mL or 3.0 mg/mL OMC. 
Neither the diet nor OMC significantly changed protein expression of inducible nitric 
oxide synthase (iNOS) in isolated aortas. Plasma levels of the inflammatory marker, 
tumor necrosis factor alpha (TNFα) were below detection after the 10-week trial. 
Superoxide dismutase (SOD), a scavenger of the free radical, superoxide, was not 
significantly different following HFD although levels of SOD were significantly higher 
in Chow rats treated with 0.6 mg/mL OMC compared to HFD rats treated with the same 
dose (p < 0.05). Lipopolysaccharides (LPS) were significantly increased following 10 
weeks of high fat intake (p < 0.05). This increase in endotoxicity was prevented by the 
high dose of OMC. HFD significantly increased fasting serum glucose levels at both 6 
weeks (p < 0.001) and 10 weeks (p < 0.025) compared to Chow controls. The high dose 
of OMC significantly prevented the hyperglycemic effects of the HFD in rats at 10 weeks 
(p = 0.021). HFD-fed rats developed hyperinsulinemia after 10 weeks of feeding (p = 
0.009), which was not prevented by OMC. The results of this study indicate that OMC 
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may be an effective strategy to help manage diet-induced hyperglycemia and 
endotoxemia. However, further research is needed to determine the mechanism by which 
OMC helps prevent hyperglycemia as measures of inflammation (TNFα) and vascular 
damage (iNOS) were inconclusive.  
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CHAPTER 1 
INTRODUCTION 
 Background. Cardiovascular disease (CVD) is on the rise in the United States 
(U.S.) at an epidemic rate. Rated as the leading cause of disease and mortality, heart 
disease accounts for 1 in 4 deaths and a total of 630,000 deaths per year in the U.S. 
Approximately $200 billion a year is spent in the U.S. for treatment and related costs of 
this disease (CDC, 2017). The human health and economic influence have warranted 
significant increases in research associated with oxidative stress and free radicals due to 
their implicated effects on the function of the endothelium and pathogenesis of many 
cardiovascular diseases.  
According to mounting evidence, a major player in the role of cardiovascular 
dysfunction and disease is oxidative stress due to the abundance and accumulation of 
reactive oxygen species (ROS) (Taniyama 2003; Landmesser 2004; Madamanchi 2005; 
Tiefenbacher 2001). In particular, it is suggested that ROS have pathophysiological 
effects on vascular endothelial cells impairing their vasodilation responsiveness 
(Taniyama 2003). Taniyama et al. (2003) attribute this pathophysiology to the production 
of the ROS superoxide, O2-, due to its ability to rapidly generate other ROS and reduce 
the bioavailability of nitric oxide (NO). 
Various enzymatic and oxidative processes generate a free radical cascade within 
the vasculature which impacts the bioavailability of NO, a key endogenous regulator of 
vasodilation. In opposition to this cascade, a variety of complimentary, endogenous 
antioxidant responses work to counteract the development of vascular pathogenesis 
(Taniyama 2003; Madamanchi 2005; Landmesser 2004). If the body cannot maintain 
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balance in these opposing processes, then accumulation of these free radicals creates a 
state of oxidative stress which, in turn, causes vascular dysfunction leading to diseases 
such as hypertension, diabetes, coronary artery disease and atherosclerosis (Taniyama 
2003).  
The addition of a specific, exogenous antioxidant can possibly provide attenuating 
properties against vascular damage. The results could provide a secondary defense 
against a variety of cardiovascular diseases.  
Purpose of Study. The purpose of this study is to determine if a soil-derived 
organometallic compound (OMC) with suspected antioxidant properties, will attenuate 
oxidative stress and inflammation and improve glucose regulation as shown by measures 
of specific enzymes, inflammatory markers, endotoxins and fasting serum glucose and 
insulin concentrations in rats fed a high-fat diet (HFD). The OMC is a proprietary blend 
provided by Isagenix International, LLC. In as much as we know, this is the first study of 
its type. This study has been approved by the Institutional Animal Care and Use 
Committee of Arizona State University (Tempe, AZ, USA). 
 Research Aim and Hypothesis. The aim of this research study is to examine the 
effects of OMC on serum glucose and insulin concentrations, enzyme activity, 
inflammatory markers and endotoxins in relation to the mitigation of high-fat induced 
vascular dysfunction in a rat model. 
  H0 : The OMC will show no measurable differences in the expression of  
  inducible nitric oxide synthase (iNOS), superoxide dismutase (SOD),  
  lipopolysaccharides (LPS), tumor necrosis factor alpha (TNFα), or serum  
  glucose and insulin levels than the vehicle, in this case, water. 
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 Definition of Terms. The following terms in this thesis are defined by this author. 
  Bioavailability – the degree to which a substance is available for   
  physiological use. 
  Low-density lipoprotein (LDL) – a form of cholesterol considered to be  
  detrimental and a risk factor of heart disease when laboratory values are  
  elevated. 
  NADPH oxidase 1 (NOX1) – a member of a family of enzymes found in  
  vascular smooth muscle cells that is responsible for the generation of  
  reactive oxygen species. 
  Oxidative stress – a condition of imbalance in the body due to   
  overabundance of reactive oxygen species and inability of internal   
  detoxifying mechanisms to match those levels.  
  Protein disulfide isomerase (PDI) – an enzyme that catalyzes protein  
  folding and is positively correlated with elevated reactive oxygen species  
  and disease states. 
  Reactive oxygen species (ROS) - a natural, toxic byproduct of normal  
  metabolism resulting from the reduction of oxygen by addition of   
  electrons. 
  Tetrahydrobiopterin (BH4) – a cofactor or “helper molecule” in the  
  production of nitric oxide by the nitric oxide synthases. 
  Vasodilation – relaxation of smooth muscle cells in the lining of a blood  
  vessel allowing a widening of the vessel and lowering of blood pressure. 
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 Abbreviations. The following are abbreviations used in this thesis. 
  iNOS – inducible nitric oxide synthase 
  LPS – lipopolysaccharide 
  NO – nitric oxide, an endogenous vasodilator 
  O2- - superoxide, a free radical 
  OMC – organometallic compound, the intervention 
  ROS – reactive oxygen species  
 Delimitations and Limitation. The nature of this study, the need for organ and 
vessel extraction necessitated a rat model as opposed to humans. Limitations of this study 
were small sample size, use of male rats, and individual housing. Use of this design may 
restrict the translation of benefits to a human population but may aid in directing further 
research. 
 
  5 
CHAPTER 2 
REVIEW OF LITERATURE 
 Cardiovascular Disease. Cardiovascular disease (CVD) is on the rise in the 
United States (U.S.) at an epidemic rate. Rated as the leading cause of disease, heart 
disease accounts for 1 in 4 deaths and a total of 630,000 deaths per year in the U.S. A 
total of approximately 735,000 people have a heart attack each year in the U.S. (CDC, 
2017). Approximately $200 billion a year is spent in the U.S. for treatment and related 
costs of this disease (CDC, 2017). The most common form of heart disease is coronary 
artery disease. This form of heart disease is characterized by a build-up in the arteries of 
cholesterol and other substances, most often referred to as plaque. The process of this 
accumulation of plaque is referred to as atherosclerosis (CDC, 2017). Coronary artery 
disease is responsible for over 370,000 individual deaths in the U.S. annually. Several 
risk factors are associated with heart disease, such as, smoking, hypertension, high 
cholesterol, genetics, lifestyle, and age. Family history and age are two factors that 
cannot be controlled. 47% of Americans have at least one of these risk factors (Fryar and 
Chen, 2012). Hingorani et al. (2000) point to the role of acute inflammation and an acute 
cardiovascular event with the suspected precurser to a cardiac event being abnormal 
endothelium-dependent vasodilation. This study also indicated the role of mild 
inflammation in the interruption of vascular tone (Hingorani, 2000). Although there is an 
apparent connection between inflammation and vasodilation, the specific mechanism by 
which the disruption occurs still eludes understanding. The possibility of simultaneous 
mechanistic opponents to healthy vascular tone as cause for dysfunction exists. It is 
widely accepted that vascular inflammation plays a part in cardiovascular disease, 
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specifically in hypertension and atherosclerosis (Touyz, 2005, Griendling et al, 2003). 
Connection to vasomotion, vascular tone and the endothelium’s role in regulation of 
these characteristics is suggested as a potential clinical indicator for assessing patients at 
risk. Inflammatory markers, such as C-Reactive protein, may aid in early detection of 
vascular degeneration and onset of disease (Landmesser, 2004). Epidemiological studies 
have implicated a correlation between potential of developing cardiovascular disease and 
inflammation, both acute and chronic (Maseri, 1997). The changes in vasculature 
endothelium due to inflammation show risk of a cardiovascular event or a slow 
progression toward atherosclerosis (Vallance, 1997). Both chronic low-grade 
inflammation and an acute inflammatory response have been associated with 
atherogenesis (Ridker, 1997). Aside from angiogenesis pathology there is another 
problem occuring due to radical oxygen species. Cell death, apoptosis, is induced by 
exposure to these free radicals that develop during these dysfunctional processes 
(Dimmeler S. , 2000). The death of cells in the endothelium contribute to the 
degenerative processes associated with endothelial dysfunction. Moreover, cell death can 
be initiated by several factors, including angiotensin II, oxidation of LDL and 
hyperglycemia (Taniyama, 2003). 
 Reactive Oxygen Species (ROS). The generation of ROS through several 
metabolic pathways and its accumulation lead to high levels of oxidative stress resulting 
in vascular dysfunction, in particular, a reduction of vasodilation (Sweazea, 2010). Due to 
the nature of ROS and the unpaired electrons they possess, these molecules scavenge 
electrons from other molecules within the vasculature. Some of these scavenging 
molecules include superoxide (O2-), peroxynitrite (ONOO-), and lipid radicals (Cai, 
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2000). Generation of a free radical cascade that overwhelms the endogenous antioxidant 
counteractive measures causes a reduction in the bioavailability of nitric oxide (NO), a 
key regulator of vasodilation (Taniyama, 2003). Nitric Oxide plays a major role as an 
endothelium-derived vasodilator and is considered of great importance (Tiefenbacher, 
2001). The pathogenesis of vascular dysfunction leads to diseases such as hypertension, 
diabetes, coronary artery disease and atherosclerosis (Niedowicz and Daleke, 2005). 
There is a general consensus that excess ROS can deluge the body’s own endogenous 
antioxidant mechanisms resulting in pathophysiology. Some research depicts the role of 
inflammation in connection to hypertension, existing either directly from a known disease 
state, such as diabetes or as an indirect result of altered function of the vasculature 
(Androwiki, 2015, Simperova, 2016).  
 Mechanisms of Vascular Dysfunction.Various methodological approaches have 
been taken in order to examine the many mechanisms associated with endothelial 
dysfunction. According to Landmesser et al the process is complicated and a multi-
stepped cascade of events. It is these factors that ultimately hinder endothelium-
dependent vasomotion (Landmesser, 2004). Vaccine-induced inflammatory response was 
measured in one study to illustrate a connection to the various cytokines that are triggered 
and their impact on the vasculature (Hingorani, 2000). In another study, inflammatory 
markers such as inducible nitric oxide synthase (iNOS) were measured and compared to 
superoxide production and nitric oxide reduction. The superoxide production was 
specifically measured using a dye to examine and quantify fluorescense microscopically 
(Simperova, 2016). There are numerous ideas as to what actually produce the free 
radicals that are capable of oxidizing biomolecules due to the nature and complexity of 
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chemical reactions in the body. Madamanchi et al. (2005) suggest a critical role of 
NADPH as the culprit in atherogenic stress. Also noted in their research was the role of 
oxidized LDL and xanthine oxidase in free radical production. Madamanchi et al. (2005) 
goes further to point out even more areas of ROS production through deficiency of the 
cofactor 5,6,7,8-tetrahydrobiopterin (BH4). In this case, this interrupts the normal 
production of NO thus reducing its bioavailability. At the same time this produces the 
free radical, superoxide. And he goes on further to point out the electron transport chain 
can become dysfunctional and also produce superoxide radicals (Madamanchi, 2005). 
Xanthine oxidase along with NADH/NADPH oxidases, peroxidases, arachidonic acid 
pathways and mitochondrial respiration to name a few are diagnosed as ROS producers 
by Cai and Harrison (Cai, 2000). In general, most researchers would agree that a 
depletion of nitric oxide plays a very important role in the reduction of vasomotion. 
These redox signalling processes, says Androwiki et al. (2015), lead to not only vascular 
dysfunction, but hypertension. Androwiki et al. (2015) goes on to suggest a strong 
correlation between the presence of protein disulfide isomerase (PDI) and ROS 
generation due to its regulation of these NADPH oxidases. This is especially noted in 
cases of hypertension. In the absence of PDI, it is supposed that angiotensin II can 
stimulate one of the NADPH enzymes called NOX1. This in turn initiates a rapid fire 
reaction producing ROS (Androwiki, 2015). Thus, there are numerous avenues of 
approach to the understanding of how ROS are formed. Many times this is a direct result 
of a chemical reaction and other times it is the result of lack of bioavailability of a 
cofactor or molecule. Whatever the case may be, conditions such as atherosclerosis 
develop due to these types of conditions (Tiefenbacher, 2001). Studies by Shinozaki et al. 
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(2004) suggest the mechanism which alters vasodilation is the reduction in NO due to the 
scavenger superoxide. Its role in electron exchange thus produces peroxynitrite (ONOO-). 
Peroxynitrite in turn, reduces the availability of NO and strengthens the resistance of 
vasomotion (Shinozaki, 2004). These events have been shown to take place in condtions 
of diabetes and/or insulin resistant states.  
 Research struggles with what is the clear indicator of vascular dysfunction due to 
the many avenues of the free radical cascade. It is clear, however, that radical oxygen 
species, despite how they were formed, have strong effects on the function of the 
vasculature. Deneau et al. (2011) point to yet another indicator of cause. It is suggested 
that the production of advanced glycation endproducts (AGE) as a result of a non-
enzymatic glycation triggers an inflammatory response which can lead to complications 
in the vasculature and circulation in individuals with type 2 diabetes. Deneau et al. (2011) 
suggests the mitochondrial dysfunction in the diabetic condition prevents the production 
of the necessary extra energy it takes to overcome the AGEs and make repairs. Taniyama 
et al. (2003) consider discrepencies in understanding that result from the nature of 
enzymatic functions and multiple roles of different molecules in this cascade toward 
oxidative stress. In fact, it is pointed out that arteries show different responses to ROS 
than do the aorta. Also noted is the behavior of vasculature associated with angiotensin II 
and catalase. These factors have inhibited the exact determinant of vasomotor tone 
(Taniyama, 2003). It is not only the free radical cascade that produces the damage. The 
fact that the endogenous mechanisms of antioxidant systems are impaired contributes to 
this accumulation of highly reactive molecules. It is this accumulation more so than the 
actual production that effects the vasculature. Study after study show the inundation of 
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the endogenous system of repair prevents it from keeping up and thus allowing damage to 
the tissues. These ROS contribute to diseases such as atherosclerosis, mutagenesis, cancer 
and ageing. Barman et al. (2017) goes on to suggest that the contribution to developing 
oxidative stress can be due to glucose oxidation, protein glycation and the production of 
endproducts (Barman, 2017). The role of oxidative stress in hypertension is seemingly 
conclusive. The loss of vasomotion due to free radical scavenging and inactivation of NO 
increase vessel pressure. This hypertensive state further contributes to other states of 
disease, such as atherosclerosis. Diabetes on the other hand contributes to the NADPH 
oxidase activity and as a result leads to the inability of the vessels to relax (Taniyama, 
2003). Sweazea et al. (2011) considered the role of increased adiposity from diet in 
cardiovascular disease. In a study of rats on a high fat diet, results indicated these animals 
developed hyperglycemia, increased fat mass, hypertension and oxidative stress 
(Sweazea et al., 2010; Sweazea and Walker 2011). Studies conducted by Sweazea et al. 
(2011) examined the effects of the diet on vasodilation and found that vasodilation was 
impaired as a result of oxidative stress, inflammation (Sweazea, 2010), and upregulated 
induced nitric oxide synthase (iNOS) activity (Sweazea and Walker, 2010) in the 
vasculature of the rats fed a high fat diet for 6 weeks. iNOS has been implicated in the 
production of superoxide radicals and therefore increasing the oxidative load on the body 
(Sweazea, 2011). The exact pathophysiological roles have yet to be determined (Stroes, 
1998). It is clear that the common denominator in these pathophysiologies is directly 
related to ROS, however, it remains to be determined how exactly this takes place and 
what preventive measures can be applied to counteract the negative effects of ROS. 
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 Therapeutic Intervention and Exogenous Supplements. Taniyama and Griendling 
(2003) refer to poor outcomes in trials involving exogenous supplementation as an 
antioxidant. Noting the diversity of pathways generating ROS, a more specific approach 
to supplementation formulation and use is advocated (Taniyama, 2003). Both the 
protagonist and antagonist relationships between nitric oxide (NO), endothelial nitric 
oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) form a very complex 
and not yet fully understood chain reaction. However, it is noted that there is a significant 
rationale to the presence, or lack thereof, and bioavailability of these molecules and the 
development of cardiovascular disease (Landmesser, 2004). Supplementation with a 
mineraloid substance has been evaluated and showed promise in regards to mitochondrial 
improvement in the diabetic cases studied (Deneau, 2011). The complexity of the state of 
disease exacerbates the negative effects of ROS production in most case studies in the 
literature. So, it is difficult to determine the mechanism involved. The counter measures 
of certain specific enzymes and also antioxidant vitamins have proven to be inhibitory to 
some extent in these processes (Dimmeler, 2000). Limitations have been presented in 
studies showing the lack of effectiveness of specific antioxidants due to their limited 
ability to scavenge free radicals. The endogenous mechanisms prove to be far superior in 
strength to any exogenous antioxidants tested. More clinical trials are necessary to 
establish a better understanding of the specific pathway (Taniyama, 2003). One study in 
particular, however, showed promising results in zinc supplementation. Zinc deficiency 
has been linked to development of oxidative stress or at least a sensitivity to its 
development. Barman et al. (2017) confirmed that partial prevention of oxidative stress 
was promoted by zinc supplementation in both aortic and hepatic tissues. The zinc 
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supplementation influenced the elevation of cardiac enzyme markers which are known to 
reduce the incidence of oxidative stress. Enzymatic reactions that are conducive to 
producing oxidative stress were reduced in activity (Barman, 2017). This discovery is 
suggestive of the mechanism by which the organometallic compound may act in my 
study. In another study, a mineraloid isolate showed promising results in its counter 
measures toward diabetes. Non-enzymatic glycation due to a diabetic state was inhibited 
and thus advanced glycation endproducts were less likely to be formed. This anti-
glycation activity increased up to 48% in the rats that were studied (Deneau, 2011).  
 Measurement of Physiological Markers. Each respective study in this review 
approached its assessment through differing test models. Sweazea et al. (2010) used 
western blot on snap-frozen rat aortas to examine change in eNOS. Through a process of 
homogenization, protein separation and double incubations, the chemiluminescence 
shown as immunoreactive bands could be visualized and quantified. This group also 
measured ROS using a fluorescence technique as well. The results concluded that diets 
high in fat and sucrose diminish endothelial vasodilation due to the dependency on nitric 
oxide. Nitric oxide was scavenged by ROS lowering its bioavailability and thus resulting 
in dysfunction of the endothelium (Sweazea et al., 2010). These methods are somewhat 
time consuming but are very cost effective and easily quantifiable.  
 Mitochondrial activity and non-enzymatic glycation were measured by Deneau et 
al (2011).  Mitochondrial activity was measured with the use of a kit which took three 
days to process and was easily read by spectrophotometry. The glycation process utilized 
the measure of fluorescence by wavelength through a micro-fluorometric analyzer. DNA 
assays were performed on fibroblasts incubated with the mineraloid solution and 
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electrophoresis was used to analyze the samples following protein extraction. The results 
suggest an improvement in mitochondrial metabolism and non-enzymatic glycation. 
Mitochondrial improvement was expressed in the upregulation of key genes that enhance 
metabolism. For these reasons, it is suggested that magnesium may play a role in this 
since it is high in concentration in the mineraloid substance. Further studies would be 
necessary to confirm these assumptions. Blood analysis and body weight were 
significantly improved in the diabetic mice of this study. Alkaline phosphatase, a sign of 
diabetes mellitus, was greatly decreased (Deneau, 2011). Landmesser et al. (2004) 
describe a process of flow-dependent dilation introduced by Celermajer et al (Celermajer, 
1992) which can monitor the health of the endothelium and effects of various stimuli on 
vasodilation (Landmesser, 2004). The study performed by Simperova et al. (2016) 
measured superoxide production through fluorescense using the dye, dihydroethidium 
(DHE). This particular dye is often used in this type of assessment. This study measured 
superoxide activity using a standard assay kit. And again this group presented another 
western blot approach to assessing inducible nitric oxide synthase. In this study some 
concurrent and contradictory results were found. Fat mass and body weight declined in 
the obese mice just as suggested in clinical studies. However, one significant result was 
the fact that genestein supplementation promoted oxidative stress and inflammation 
which was contrary to their hypothesis. This correlates with higher levels of the radical, 
superoxide. iNOS, an infammatory marker, was also increased in the vasculature 
(Simperova, 2016). In a study designed to evaluate superoxide production by endothelial 
nitric oxide synthase, one group examined recombinant bovine eNOS using a kit assay 
and through electron spin resonance, a spin trapping process. This was further processed 
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and evaluated by microwave frequency measuring magnetic field. The effects of 
cofactors involved in eNOS activity were also measured using luminescence 
spectroscopy. The inhibition of both superoxide and NO could be assessed in this 
manner. As predicted, the superoxide radicals increased after treatment with the NADPH 
treatment. And the addition of tetrahydrobiopterin (BH4) conclusively decreased 
superoxide production. Further conclusions included in this study show the heme domain, 
alone controls the production of eNOS-mediated superoxide radicals (Stroes, 1998). One 
limitation of the study is the use of isolated enzymes compared to experiments in living 
cells, not to mention the other risk factors associated with atherosclerosis. Barman et al. 
(2017) explored measuring plasma lipid profiles. Both methylation of fatty acids and 
triacylglycerols (TAGs) were measured using assays demonstrated in other literature. 
RNA isolation was performed to assess genetic upregulation. Western blot technique was 
used according to standard protocols to evaluate protein expression of oxidative stress 
markers. Results showed significant decreases in the size and weight of hearts in the rats 
supplemented. However, this is indicated only in the low-dose intervention group as no 
significant difference was exemplified in the high dose group. Zinc supplemented rats 
also showed drops in ROS and peroxide levels by as much as 25%. In comparison, the 
control groups showed much higher levels of both, as well as, higher levels of most all 
antioxidant enzymes. The rats given the supplement had much lower cholesterol and 
TAGs in the heart muscle. Phospholipid levels decreased in the intervention group by as 
much as 34%, a significant change. Apoptosis gene regulation was reduced by zinc 
supplementation, whereas, upregulation of beneficial gene sequencing was improved. 
While this study, in fact, offers lucrative evidence of success, it still necessitates further 
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examination on the effects against oxidative stress. The evidence depicting a definitive 
inverse reaction with the use of supplementation sets a clear course for future research. 
The results concluded in this study offer promising potential in exogenous supplemention 
advancements to counteract ROS. However, as with most studies in this review, the 
verdict is not yet in.  
 Hingorani (2000) demonstrated a vaccine induced inflammatory response using a 
salmonella typhi vaccine. Various cytokines, inflammatory markers, were measured by 
ELISA testing. Blood flow in the forearm in response to various vasodilators was 
measured using plethysmography. And the brachial artery dilation, both pre and post, was 
measured though the use of ultrasound. The results showed increased white cell count, an 
immune response which demonstrates inflammation. The cytokines were elevated. There 
was no change in heart rate or blood pressure or body temperature. Forearm blood flow 
increased as well. Vasodilation response was inhibited following the vaccination. The 
control group showed variable changes in dilator responses but no changes in any of the 
other assessments. The results of this study concluded that even though vasorelaxation 
was inhibited, it was only temporary in this case (Hingorani, 2000). It could be observed 
in this study that the temporary reaction was due to a temporary stimulus, the vaccine. 
Further study on subjects in pre-conditions of disease state may exhibit more long-term 
responses as they would be in a more compromised state. Despite the insight provided, 
this study did not provide an adequate model to make any promising conclusions. This 
study leaves the reader feeling somewhat incomplete. 
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CHAPTER 3 
METHODS AND MATERIALS 
 Experimental Groups. Six-week old male, Sprague-Dawley rats (Envigo, 
Indianapolis, IN) were randomly separated into two groups and then randomly divided 
into 3 intervention subgroups. The Chow and HFD control subgroups contained 10 and 8 
rats, respectively. The Chow and HFD intervention subgroups each contained 6 rats. 
Mean weight of rats at the start of the study was 150 grams. Male rats were preferred 
over female due to ovulation and higher risk for cardiovascular disease among female 
rats. Rats were housed individually to allow for the analysis of the fecal microbiome for a 
separate study. Visual, auditory and olfactory contact with other rats was provided. All 
cages were identical and in the same facility location. Environment was structured to 
provide 12:12h light-dark cycles (see Figure 1). 
 
Figure 1. Experimental Design (n = 10 Chow, n = 8 HFD, n = 6 Chow and HFD 
intervention groups). OMC = organometallic compound, HFD = high fat diet. 
 
 One group of rats was fed a standard rodent chow diet comprised of 18.6% 
protein, 44.2% carbohydrates, and 6.2% fat kcal quantities (2018; Harlan Teklad; 
Rat Model
Regular 
Chow
Vehicle 
(Water)
0.6 mg/mL 
OMC
3.0 mg/mL 
OMC
High Fat 
Chow
Vehicle 
(Water)
0.6 mg/mL 
OMC
3.0 mg/mL 
OMC
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Appendix A). The other group was fed a HFD comprised of 20% protein, 20% 
carbohydrates, and 60% fat kcal quantities (D12492; Research Diets, Inc.; Appendix B). 
Rats were fed the allocated diets for 10 weeks. Diets, water and cages were replaced 
every third day to maintain quality. Food and water was always readily available to rats.  
The OMC with suspected antioxidant properties was used as the intervention. Each of the 
3 intervention subgroups from the chow and HFD groups were provided a vehicle (plain 
water), 0.6 mg/mL OMC intervention, or 3.0 mg/mL OMC intervention, respectively. 
The intervention was administered in their drinking water throughout the 10-week 
feeding study.  
 At the end of the 10-week study, rats were euthanized with an overdose of sodium 
pentobarbital (200mg/kg body mass, i.p.) and blood was collected by cardiac puncture for 
the analysis of plasma nitric oxide (total nitrates and nitrites). Following blood 
collections, the thoracic aortas were isolated and divided into two segments. One segment 
of the thoracic aorta was snap-frozen in liquid nitrogen for western blotting procedures to 
examine changes in the protein expression of iNOS and the other segment was embedded 
in optimal cutting temperature (OCT) compound prior to freezing for tissue 
cryosectioning and analysis of oxidative stress, specifically superoxide, in a future study. 
Western Blots 
 The snap-frozen aortic tissue was used to measure total iNOS, an inflammatory 
marker that can overproduce NO. Procedures for western blot tests follow the laboratory 
protocol established by Dr. Karen Sweazea (Sweazea, Lekic, Walker 2010).  
 Thoracic aorta segments were transferred to microcentrifuge tubes containing 
microbeads and ice-cold buffer containing 10mM Tris (pH 7.6), 1mM EDTA, 1% triton 
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X-100, 0.1% Na-deoxycholate, and 10uL protease phosphatase inhibitor (HALT, Cat. 
No. 1861281; Thermo Scientific, Waltham, MA) were added to the tubes to prevent 
protein breakdown. The samples were then homogenized using a BeadBug Benchtop 
homogenizer (3.0mm zirconium beads; Benchmark Scientific, Edison, NJ, USA). The 
resultant homogenate was then transferred to a new centrifuge tube and centrifuged at 
4000g (relative centrifugal force) for ten minutes at 4˚C to remove any soluble debris. 
The supernatant was analyzed for total protein content using the Bradford method micro-
assay protocol (Bio-Rad, Hercules, CA). Tissue sample proteins (25 μg/lane) were 
resolved by 7.5% Tris-HCL sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (Bio-Rad, Hercules, CA) at 200V for a period of 35 minutes at room 
temperature. Gel electrophoresis was used to separate the proteins by molecular weight 
which were then transferred to Immuno-blot polyvinylidene difluoride (PVDF) 
membranes (Bio-Rad, Hercules, CA) at 100V for 90 minutes. The PVDF membranes 
were then incubated overnight at 4˚C in blocking buffer (100 mL Tween/Tris-buffered 
saline (TTBS) consisting of 3% BSA. Following overnight incubation, the membranes 
were washed in TTBS and incubated for 4 hours at room temperature with mouse 
monoclonal antibody for iNOS detection (1:1500; Cat. 610431; BD Transduction 
Laboratories, San Jose, CA). Rabbit polyclonal antibody to β-actin was used as the 
control (1:10,000; Cat. Ab8227; AbCam, Cambridge, MA). Tri-buffered saline (TBS) 
washes followed by exposure to chemiluminescence western blotting substrate for 1 
minute demonstrated chemiluminescent signals (Thermo Scientific, Rockford, IL). The 
signals were then detected by exposure to x-ray film (Kodak X-OMAT, Thermo Fisher 
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Scientific, Pittsburgh, PA) and ImageJ software was used to analyze the densitometry of 
interest.    
Tumor Necrosis Factor α 
 Tumor necrosis factor alpha (TNF α), a cytokine involved in systemic 
inflammation, was analyzed in plasma samples collected at 10 weeks using a Rat TNF 
alpha ELISA Kit (Cat. ER3TNFA, ThermoFisher Scientific, Rockford, IL) per 
manufacturer’s protocol (see Appendix C).  
Superoxide Dismutase 
 Superoxide dismutase (SOD) is an enzyme that catalyzes the dismutation or 
fractionation of the free radical superoxide, O2- into molecular oxygen or hydrogen 
peroxide. Plasma SOD activity at 10 weeks were analyzed using the Superoxide 
Dismutase Activity Assay Kit (Cat. 706002, Caymen Chemical, Ann Arbor, MI) per 
manufacturer’s protocol (See Appendix D). 
Lipopolysaccharides 
 Lipopolysaccharides (LPS), also known as endotoxins are found in the 
peptidoglycan layer of gram-negative bacteria. When released into the bloodstream, these 
toxins initiate an inflammatory response. Plasma analyses of LPS were performed using 
Pierce™ LAL Chromogenic Endotoxin Quantitation Kit (Cat. 88282, ThermoFisher 
Scientific, Rockford, IL) per manufacturer’s protocol (See Appendix E). 
Fasting Serum Glucose 
 Glucose is a 6-carbon, monosaccharide utilized as the body’s primary energy 
source. Elevated serum levels have been linked to diabetes and hypertension. A 
colorimetric assay kit (Cat. 10009582, Caymen Chemical, Ann Arbor, MI) was used 
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according to manufacturer’s protocol to quantitate fasting serum glucose levels after 6 
and 10 weeks (See Appendix F). 
Fasting Serum Insulin 
 Insulin is a hormone secreted by the pancreas as a blood glucose regulator. Lack 
of insulin or cellular resistance to insulin action is linked to diabetes and hypertension. 
Fasting serum insulin quantification was performed according to manufacturer’s protocol 
using the Ultra-Sensitive Rat Insulin ELISA Kit (Cat. 90060, Crystal Chem USA, 
Downers Grove, IL; See Appendix G). 
Statistics 
 Comparison within and between group data was performed for total iNOS protein 
expression as well as plasma SOD and LPS using two-way analysis of variance 
(ANOVA) with diet and dose of OMC as factors.  Fasting serum glucose and insulin 
levels were analyzed by two-way RM ANOVA with diet and dose of OMC as factors 
comparing within and between group data. Tukey post-hoc analyses were used to confirm 
differences in statistically significant data. Means ± standard error of the mean was used 
to report the data. Sigmastat 3.0 (Systat Software, San Jose, CA) was used for all 
statistical analyses.  
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CHAPTER 4 
RESULTS 
 Effects of OMC on iNOS expressions. There was no statistically significant 
difference between the Chow fed rats and HFD rats (p = 0.752). Two-way ANOVA 
showed no statistically significant difference between the HFD control rats, rats treated 
with 0.6 mg/mL OMC or HFD rats with 3.0 mg/mL OMC (p =  0.708).  
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Figure 2. iNOS expression between respective HFD and Chow control groups (p > 0.05) 
and between HFD control and intervention groups (p > 0.05). iNOS = inducible nitric 
oxide synthase, HFD = high fat diet.  
 
 Effects of OMC on plasma TNFα inflammatory marker. Plasma TNFα values 
were below detection.  
 Effects of OMC on SOD levels in plasma at week 10. Two-way ANOVA analyses 
show HFD 0.6 mg/mL OMC resulted in significantly lower SOD concentrations 
Chow (n = 4) 
HFD (n = 4) 
HFD 0.6 (n = 3) 
HFD 3.0 (n = 3) 
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compared to Chow fed rats treated with 0.6 mg/mL OMC (p < 0.05). All other group 
comparisons showed no statistical significant difference (p > 0.05; Table 1).  
 
Table 1: Plasma SOD Levels at Week 10  
Plasma SOD Activity     (U/mL) Mean ± SEM (n) 
Chow 1.31 ± 0.16 (9) 
Chow + 0.6 mg/mL OMC 1.62 ± 0.14 (6) 
Chow + 3.0 mg/mL OMC 1.28 ± 0.16 (6) 
HFD 1.17 ± 0.08 (8) 
HFD + 0.6 mg/mL OMC 1.18 ± 0.09 (6) * 
HFD + 3.0 mg/mL OMC 1.13 ± 0.16 (6) 
 
Data expressed as mean ± SEM (n). Data analyzed by two-way RM ANOVA with Tukey 
posthoc analyses, * p < 0.05 vs. respective Chow. SOD = superoxide dismutase, HFD = 
high fat diet, OMC = organometallic compound. 
 
 Effects of OMC on plasma lipopolysaccharides (LPS). Data analyzed by two-way 
ANOVA showed significantly increased plasma LPS in HFD control compared to Chow 
control rats (p < 0.05). Additionally, 3.0 mg/mL OMC prevented the increase in plasma 
LPS in rats fed a HFD (p < 0.05). All other groups showed no statistical significance (p > 
0.05; Table 2). 
 
Table 2: Plasma LPS Levels at Week 10 
Plasma LPS Concentration  
(EU/mL) 
Mean ± SEM (n)      
Chow 0.395 ± 0.029 (6) 
Chow + 0.6 mg/mL OMC 0.294 ± 0.026 (4) 
Chow + 3.0 mg/mL OMC 0.400 ± 0.089 (6) 
HFD 0.620 ± 0.061 (3) * 
HFD + 0.6 mg/mL OMC 0.441 ± 0.075 (6) 
HFD + 3.0 mg/mL OMC 0.303 ± 0.024 (6) # 
 
Data expressed as mean ± SEM (n). Data analyzed by two-way RM ANOVA with Tukey 
posthoc analyses, * p < 0.05 vs. respective Chow, # p < 0.05 vs. respective HFD control. 
LPS = lipopolysaccharides, HFD = high fat diet, OMC = organometallic compound.  
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 Effects of OMC on serum glucose levels. Two-way RM ANOVA analyses (see 
Table 3) showed significantly greater fasting serum glucose concentrations in HFD rats 
compared with Chow fed animals at week 6 (p < 0.001) and week 10 (p = 0.025). The 
high dose of OMC prevented hyperglycemia in HFD rats at 10 weeks (p = 0.021) and a 
tendency to decrease fasting serum glucose from week 6 to week 10 in HFD rats (p = 
0.085). The low dose of OMC tended to lower serum glucose in HFD rats at 10 weeks (p 
= 0.067). There were no significant differences in serum glucose among any of the Chow 
groups (p > 0.05).  
 
Table 3: Serum Glucose Levels at Week 6 and 10 
 Week 6  Week 10  
Serum Glucose  
(mM/L) 
Mean ± SEM  (n) Mean ± SEM (n) 
Chow 6.88 ± 0.28 10 7.08 ± 0.17 10 
Chow + 0.6 mg/mL OMC 7.43 ± 0.36 6 7.34 ± 0.30 6 
Chow + 3.0 mg/mL OMC 6.73 ± 0.45 6 7.01 ± 0.17 6 
HFD 8.83 ± 0.41 * 8 8.32 ± 0.33 * 8 
HFD + 0.6 mg/mL OMC 8.01 ± 0.34 6 7.30 ± 0.04 6 
HFD + 3.0 mg/mL OMC 7.91 ± 0.29 6 7.07 ± 0.19 # 6 
 
Data expressed as mean ± SEM (n). Data analyzed by two-way RM ANOVA with Tukey 
posthoc analyses, * p < 0.05 vs. respective Chow, # p < 0.05 vs. respective HFD control. 
HFD = high fat diet, OMC = organometallic compound.  
 
 Effects of OMC on serum insulin levels. Two-way RM ANOVA analyses (see 
Table 4) showed significant hyperinsulinemia in the HFD rats at week 10 compared to 
Chow controls (p = 0.009). HFD rats treated with 0.6 mg/mL OMC tended to have a 
higher fasting serum insulin level at week 6 compared to the respective Chow rats, 
however, it was not statistically significant (p = 0.064). In addition, HFD rats tended to 
have higher fasting serum insulin concentrations at week 6 compared to Chow rats (p = 
0.066). There were no significant effects of OMC on fasting insulin concentrations. 
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Table 4: Serum Insulin Levels at Week 6 and 10 
 Week 6  Week 10  
Serum Insulin 
(mU/L) 
Mean ± SEM (n) Mean ± SEM (n) 
Chow 12.9 ± 2.73 10 12.2 ± 1.27 10 
Chow + 0.6 mg/mL 
OMC 
14.7 ± 3.28 6 16.3 ± 2.99 6 
Chow + 3.0 mg/mL 
OMC 
12.4 ± 2.11 6 15.2 ± 1.69 6 
HFD 29.2 ± 5.52 8 32.8 ± 3.80 * 8 
HFD + 0.6 mg/mL OMC 34.6 ± 7.41 6 34.3 ± 6.55 6 
HFD + 3.0 mg/mL OMC 30.3 ± 9.18 6 25.8 ± 5.36 6 
 
Data expressed as mean ± SEM (n). Data analyzed by two-way RM ANOVA with Tukey 
posthoc analyses, * p < 0.05 vs. respective Chow, # p < 0.05 vs. respective HFD control. 
HFD = high fat diet, OMC = organometallic compound. 
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CHAPTER 5 
DISCUSSION 
 Discussion of Results. Oxidative stress develops when oxidizing mechanisms in 
the body overwhelm antioxidant protective measures. This imbalance has potential to 
cause cellular damage in the vasculature (Stocker, 2004). Vascular damage sparks events 
that lead to cardiovascular diseases, such as atherosclerosis and hypertension (Schulze, 
2005). The main culprit in the development of oxidative stress is free radicals. Free 
radicals are molecules containing unpaired electrons (Halliwell, 1999). Damage occurs 
when free radicals generate more free radicals from other molecules rather than pairing to 
form non-radical products (Schulze, 2005). Normal vascular processes are interrupted by 
oxidative stress, specifically synthesis of nitric oxide (NO) by nitric oxide synthases. NO 
is important in the vasodilation of vascular smooth muscle cells lining the blood vessels 
(Landmesser, 2004). Lack of vasodilation affects vascular tone which can lead to 
hypertension, a precursor to heart disease. Numerous physiological markers can assess 
the presence or potential of vascular dysfunction. Exogenous supplementations have been 
introduced as a therapeutic intervention for oxidative stress, but due to the complexity 
and nature of the mechanisms involved they are difficult to target with exogenous 
supplementation and often fall short (Conti, 2016). 
 This study was conducted assuming the null hypothesis (Ho) which states the 
OMC will show no measurable differences in the expression of inducible nitric oxide 
synthase (iNOS), superoxide dismutase (SOD), lipopolysaccharides (LPS), tumor 
necrosis factor alpha (TNFα), or serum glucose and insulin levels than the vehicle, in this 
case, water. Failure to reject the null hypothesis on several measures exist, including 
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iNOS, TNFα, serum insulin concentration and SOD. iNOS presents as a defense 
mechanism during oxidative stress and increases intracellular nitric oxide to toxic levels. 
As hypothesized, there were no significantly measurable differences in the application of 
the OMC intervention on iNOS protein expression within the aorta. Control groups also 
show lack of significant differences in aorta iNOS protein expression. TNFα levels were 
below detection in the assay and were thus inconclusive. Fasting serum insulin 
concentrations show a tendency towards greater fasting serum insulin at week 6 and 
significantly greater insulin concentrations at week 10 in HFD control animals compared 
to the respective Chow control which is suggestive of the development of insulin 
resistance in the HFD group. Free fatty acids (FFAs) circulating in the blood stream have 
been linked to the development of insulin resistance and hyperinsulinemia (Zhang, 2014). 
Jucker et al. (1997) confirmed that HFD-induced insulin resistance impairs glucose 
uptake in rats which correlates with both fasting serum insulin and fasting serum glucose 
levels in this study. FFAs deploy inflammatory responses which further contribute to 
cardiovascular complications, including atherosclerosis (Hummasti, 2010). There was no 
exhibited effect of OMC on fasting serum insulin concentrations. The statistical 
difference in SOD between the respective 0.6 mg/mL OMC groups was most likely due 
to the rise in SOD levels observed in the Chow group. There was no significance within 
the HFD groups demonstrating that the OMC intervention had no impact. SOD as an 
endogenous, antioxidant defense mechanism is of great importance. The nature of this 
enzyme provides a natural protection against the dismantling of NO by the free radical, 
superoxide. Thus, it protects vasorelaxation response and inhibits vasoconstriction 
(Fukai, 2011). As stated previously, this protection is overwhelmed under oxidative 
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stress. Exogenous reinforcements are of considerable interest in preempting the disease 
process. Despite the findings of this study, consideration should be given to further 
research in antioxidant therapies.  
 Other markers examined in this study suggest a rejection of the null hypothesis 
(Ho). LPS levels show a significant impact in the HFD 3.0 mg/mL OMC as it prevented 
the increase of plasma lipopolysaccharides. In addition to this confirmation, the 
comparative control groups show the HFD significantly higher in LPS than the Chow 
indicating increased levels of endotoxins due to a high-fat diet. The findings are 
consistent with current research on a high-fat diet, inflammation and endotoxemia 
(Wellen, 2005). Endotoxicity has also been linked to insulin resistance (Mehta, 2010) 
which is indicated in this study by both increased lipopolysaccharides and higher serum 
insulin levels in the HFD rats. Results also show a positive effect of the high dose of 
OMC on endotoxicity. Research has shown that consumption of high fat or high sucrose 
diet leads to metabolic syndrome and diseases such as diabetes (Panchal, 2011). In cases 
of metabolic syndrome due to over-nutrition, development of endotoxemia can occur due 
to increased intestinal permeability (Frazier, 2011). Zhou et al. ( 2014) examined 
metabolic disease induced by a high-fat and high-sugar diet in a rat model and found LPS 
levels to be elevated along with blood glucose and insulin levels. Insulin resistance also 
showed significantly high levels (Zhou, 2014). Fasting serum glucose levels were 
significantly increased at both week 6 and week 10. Consistent with existing research 
(Wei, 2009), the control group comparison showed the HFD induced elevated glucose 
levels. The prevention of elevated serum glucose levels with the 3.0 mg/mL OMC 
intervention signified significant impact of the treatment on fasting glucose and thus 
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glucose regulation. The reduction of blood glucose levels is key in the prevention of the 
formation of advanced glycation products (AGEs) which are conducive to the 
progression of diabetes. Deneau et al. (2011) showed significant anti-glycation activity 
using a mineraloid substance with suspected antioxidant properties which is consistent 
with the current findings. The Deneau study showed various gene expressions, including 
SOD, involved in mitochondrial repair were also increased, enhancing antioxidant 
protection (Deneau, 2011). Other research also showed improvement of mitochondrial 
function linked to prevention of insulin resistance (Peterson, 2003). The tendency toward 
reduction of glucose levels with the lower dose of 0.6 mg/mL OMC are consistent with 
the high dose OMC intervention, however, they were not significant.  
 The organometallic compound in this study was composed of a tri-mineral blend 
whose exact mineral composition is unknown. It is known that vitamins and trace 
minerals such as copper, selenium, and zinc play key roles in many biological processes 
(Shils, 1999). And studies have indicated a relationship between micronutrients and 
antioxidant potential (Evans, 2001). Deneau et al. (2011) measured the upregulation of 
gene expression using a mineraloid substance, similar to OMC in this study, containing 
numerous trace minerals and found the copper/zinc-dependent superoxide dismutase gene 
to be noticeably higher. A 2009 survey of 300 registered dieticians examined the 
likelihood of recommending supplements and for what purpose (Dickinson, 2012). The 
Dickinson et al. (2012) study confirmed that supplement recommendation was prevalent 
for bone health, nutrient deficiency, and overall health and wellness. Studies have also 
shown a strong connection between heart failure and levels of selenium, copper and zinc 
(McKeag, 2012). Unfortunately, specific studies that examine the connection between 
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diet and health have been limited with their focus on one single nutrient and disregarding 
the interaction of a specific nutrient and foods (Movassagh, 2017). It is important to note 
that despite this narrow approach to studying micronutrients and health, strong evidence 
supports the important role of micronutrients in the prevention of disease. Copper, 
selenium and zinc have been implicated in the pathogenesis of diabetes (Ozenc, 2015). 
Zinc is vital to insulin synthesis and secretion (Victorinova, 2009). Deficiency of 
magnesium has been linked to insulin resistance and diabetic complications (Praveeena, 
2013). Selenium is a component of the antagonist response to free radicals by exhibiting 
antioxidant properties and aiding other processes (Laclaustra, 2010). The role of selenium 
and zinc are important in the action of superoxide dismutase (SOD) and its ability to 
dismantle superoxide radicals (Ruiz, 1998). Forte et al. (2013) suggested a connection 
between copper levels and glucose intolerance. Copper deficiency in rats has also been 
indicated in the reduction of activity of Cu-dependent enzymes, such as SOD (Roughead, 
1999). A study of Zucker diabetic rats by Kim et al. (2014) examined the decrease in 
SOD activity and found it due to glycosylation of the Cu/Zn enzyme (Kim, 2014). 
Selenium also has a significant role to play in antioxidant protection. Selenium 
contributes to physiologically protective measures by way of conversion into 
selenocysteine (Berry, 1993). Ruseva et al. (2012) suggest the importance of endothelial 
selenoproteins in vascular tone, superoxide/NO balance, apoptosis, and cellular adhesion 
expression. Sprague-Dawley rat aortas were examined in a study on selenium and its 
potential atheroprotective role (Stupin, 2017). Stupin et al. (2017) stated the illusory 
mechanism behind the protection of vascular function could not be determined. 
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 This study provides supportive evidence of current thought on the relationship 
between HFD and hyperglycemia-induced cellular damage (Zhang, 2014). The 
generation of ROS and the increase in oxidative stress due to hyperglycemia has been 
noted in numerous studies (Wei 2009; Wang 2006). As much of the published research 
suggests, the mechanism behind antioxidant support in vascular health has not been 
concluded. It leaves research still pondering what may be the most effective approach to 
supplemental intervention in cardiovascular disease (Zureik, 2004). However, strong 
support is suggested for the use of exogenous mineral supplementation in the 
pathophysiology of cardiovascular disease. This study enforces the need to continue with 
further research in the area of exogenous supplementation and the examination of OMC 
and any potential of toxicity. The minerals suggested as possible components of OMC in 
this study each have toxicity levels as recommended by the U.S.D.A. (Food and Nutrition 
Board, 2018). Consideration should also take into account the difference in the 
physiology of rats and humans in regards to levels of toxicity. Minerals are necessary in 
the biology of humans and, therefore, pose no threat from that standpoint. However, 
consumption of minerals are only needed in minute doses.  
  31 
CHAPTER 6 
CONCLUSION 
 It is a fair prediction that studies such as these show significant promise in the 
application and use of exogenous supplementation as a possible preventive measure 
against free radical accumulation, oxidative stress and the resultant vascular damage. It is 
also safe to say that this type of intervention is necessary and therefore warrants further 
research into the applicability of exogenous supplementations. Further studies should be 
directed toward the specific biological mechanisms that are impeded or encouraged. This 
approach toward specificity could possibly have major implications in the decceleration 
of disease progress. Consideration must be given to the significance of results in regard to 
hyperglycemia and insulin resistance. It is important to note the impact of this 
organometallic compound on the reduction of lipopolysaccharides and levels of 
endotoxicity as well as prevention of hyperglycemia in animals fed a high fat diet. 
Current research is directed in large at the correlation between gut health and 
physiological status. The OMC in this study may play a key role in connecting the gut to 
vascular disease through regulation of endotoxins. Considering the overwhelming 
exposure to environmental toxins and negative factors that are uncontrollable, antioxidant 
measures must be introduced to attenuate the progression of existing diseases into 
epidemic proportions. It is also noteworthy that many of these studies are evaluated in the 
rat model. This has its own complications in the translation to human subjects. Yet, once 
established as promising in the rat model, these food items can easily be tested in human 
subjects since many of those showing positive results are already approved for human 
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consumption. This will translate into a much faster intervention against the underlying 
mechanisms behind cardiovascular disease.  
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